摘要
众所周知干扰素应答在慢性丙型感染病毒感染中是下调的。特别是几项研究表示那些患有慢性HCV感染具有干扰素刺激基因的高自然水平的的患者不能实现病毒的清除以及对于聚乙二醇化干扰素α和利巴韦林的治疗具有较差的应答性。与其他HCV感染患者相比,负责较高内源性的ISG表达的病毒和(或)宿主因子仍有待确定。然而, III型干扰素特别是新发现的拉姆达干扰素(L)4基因,似乎在驱动ISG反应和促进HSV持久性的建立中起主要作用。本综述的重点阐述近期ISG应答和IFNλ基因因子是如何影响HCV感染的临床结果,强调了在当前抗病毒治疗中使用直接抗病毒剂的影响。
关键词: 干扰素,干扰素刺激基因,白细胞介素-28B, 干扰素拉姆达4, 直接抗病毒剂, 先天免疫
图形摘要
Current Drug Targets
Title:Role of Interferons in Chronic Hepatitis C Infection
Volume: 18 Issue: 7
关键词: 干扰素,干扰素刺激基因,白细胞介素-28B, 干扰素拉姆达4, 直接抗病毒剂, 先天免疫
摘要: It is known that the production of and/or response to interferon (IFN) are deregulated during chronic hepatitis C virus (HCV) infection. In particular, several studies have shown that patients with chronic HCV infection who have a high natural level of IFN-stimulated genes (ISGs) do not achieve viral clearance and have a poor response to treatment with pegylated IFNα and ribavirin. The viral and/or host factors that are responsible for the higher endogenous ISGs expression in some HCV infected patients compared to others remain to be determined. However, type III IFNs, and in particular the new discovered IFN lambda (L) 4 Gene, appear to play a dominant role in driving ISGs response and in contributing to the establishment of HCV persistence. This review focuses on recent studies on how the ISGs response and the IFNλ genetic factors (interleukin-28B and IFNL4) affect the clinical outcome of HCV infection highlighting their impact in the current antiviral therapies with direct acting antiviral agents.
Export Options
About this article
Cite this article as:
Role of Interferons in Chronic Hepatitis C Infection, Current Drug Targets 2017; 18 (7) . https://dx.doi.org/10.2174/1389450117666160201112632
DOI https://dx.doi.org/10.2174/1389450117666160201112632 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Sex Hormones in Regulating Innate Immune Protection against HIV in the Human Female Reproductive Tract
Current Immunology Reviews (Discontinued) A Computational Analysis of Indomethacin Derivative as Tubulin Inhibitor: Insights into Development of Chemotherapeutic Agents
Combinatorial Chemistry & High Throughput Screening Clinical Pharmacology of Systemic Analgesics in Neonates
Current Drug Therapy Neuropathic Pain: Models and Mechanisms
Current Pharmaceutical Design Use of Lactobacilli and their Pheromone-Based Regulatory Mechanism in Gene Expression and Drug Delivery
Current Pharmaceutical Biotechnology Gene Therapy Approaches in an Autoimmune Demyelinating Disease: Multiple Sclerosis
Current Gene Therapy Natural Moieties as Anti-Inflammatory Agents-Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Synthesis and Biological Activities of 2,6-Dihydroxy-4-Isopentenyloxychalcone as an Antimicrobial and Anti-Inflammatory Compound
Medicinal Chemistry New Insights into Chemistry and Anti-Infective Potential of Triazole Scaffold
Current Medicinal Chemistry Effects of Hypoxia and Ischemia on MicroRNAs in the Brain
Current Medicinal Chemistry Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment
Current Pharmaceutical Biotechnology Plant Defensins and Defensin-Like Peptides - Biological Activities and Biotechnological Applications
Current Pharmaceutical Design N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain
Current Pharmaceutical Design Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics
Current Pharmaceutical Design Inhibitors of the Metalloproteinase Anthrax Lethal Factor
Current Topics in Medicinal Chemistry In the Crosshairs: NF-κB Targets the JNK Signaling Cascade
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Editorial [Hot Topic: Simian Immunodeficiency Virus Pathogenesis (Guest Editor: Donald Sodora)]
Current HIV Research The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Gastrointestinal Involvement in Children and Adolescents with Rheumatic Diseases
Current Rheumatology Reviews Inhibition of Sumoylation Alleviates Oxidative Stress-induced Retinal Pigment Epithelial Cell Senescence and Represses Proinflammatory Gene Expression
Current Molecular Medicine